Epic Update : Aurobindo Pharma

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Ondansetron Injection USP 2rng/mL packaged in 40mg/20mL Multiple-dose Vials (ANDA 202599) and Ondansetron Injection USP 2mg/mL packaged in 4mg/2mL Single-dose Vials, Preservative-free (ANDA 202600).

Get Free Penny Stock Tips,MCX Tips,Stock Tips,Forex Tips & NCDEX Tips,Commodity Tips,Share Tips,commodity tips free trial, nifty free tips,commodity trading tips, shares tips, ShareMarket Tips, Stock Market Tips, free stock tips on mobile,  Stock trading tips,Intraday Tips.